VA
OGN icon

Verdad Advisers’s Organon & Co OGN Stock Holding History

Verdad Advisers’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,000
Closed -$101K – 161
2023
Q4 		$101K Sell
7,000
-10,800
-61% -$147K 0.2% 53
2023
Q3 		$309K Sell
17,800
-200
-1% -$4.17K 0.47% 49
2023
Q2 		$375K Buy
+18,000
New +$391K 0.59% 45

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Verdad Advisers's OGN Position: Q1 2024 in Review

Verdad Advisers sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 7,000 shares — an estimated $101K sold.

Verdad Advisers first reported a position in OGN in Q2 2023 and held it in 3 quarters. The position peaked at $375K in Q2 2023. 721 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

  • Verdad Advisers reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
  • Verdad Advisers sold 7,000 Organon & Co shares in Q1 2024, an estimated $101K.
  • Verdad Advisers first reported a position in Organon & Co in Q2 2023 and held it in 3 quarters.
  • Verdad Advisers's Organon & Co position peaked at $375K in Q2 2023.
  • 721 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Verdad Advisers's 13F filing for Q1 2024, filed 14 May 2024.